List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 747 studies with search of: "Pancreatic Neoplasms"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Conditions: Recurrent Colon Cancer;   Extensive Stage Small Cell Lung Cancer;   Stage III Pancreatic Cancer;   Stage III Rectal Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Stage III Non-Small Cell Lung Cancer;   Stage I Pancreatic Cancer;   Stage II Non-Small Cell Lung Cancer;   Stage IVB Pancreatic Cancer;   Stage II Pancreatic Cancer;   Stage III Colon Cancer;   Stage IVA Pancreatic Cancer
Interventions: Drug: Detox-B adjuvant;   Drug: ras peptide cancer vaccine
2 Recruiting Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
Conditions: Adenocarincoma of Pancreas;   Stage III Pancreatic Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer
Interventions: Drug: paclitaxel;   Drug: oxaliplatin;   Drug: leucovorin;   Drug: 5-fluorouracil;   Drug: glutathione;   Drug: calcium and magnesium;   Procedure: Chemotherapy;   Procedure: Chemoprotection;   Procedure: Complementary and alternative therapy
3 Withdrawn Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage I Pancreatic Cancer;   Stage II Pancreatic Cancer;   Stage III Pancreatic Cancer
Interventions: Drug: bevacizumab;   Drug: gemcitabine hydrochloride;   Procedure: adjuvant therapy;   Procedure: anti-cytokine therapy;   Procedure: antiangiogenesis therapy;   Procedure: antibody therapy;   Procedure: biological therapy;   Procedure: chemotherapy;   Procedure: conventional surgery;   Procedure: growth factor antagonist therapy;   Procedure: monoclonal antibody therapy;   Procedure: surgery
4 Active, not recruiting Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Intervention: Drug: RTA 402
5 Completed A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Cancer;   Nonresectable Pancreatic Cancer
Intervention: Biological: CG 8020 and CG 2505
6 Terminated Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint
Conditions: Cancer of Pancreas;   Cancer of the Pancreas;   Pancreas Cancer;   Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: panitumumab
7 Recruiting A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   Metastatic Pancreatic Cancer;   Pancreatic Cancer
Interventions: Other: Placebo;   Drug: AMG 479;   Drug: AMG 655
8 Recruiting Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder
Condition: Pancreatic Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: biopsy
9 Recruiting Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Conditions: Locally Advanced (Unresectable) Pancreatic Cancer;   Metastatic Pancreatic Cancer
Interventions: Drug: gemcitabine;   Drug: Erlotinib;   Radiation: low dose fractionated radiotherapy
10 Recruiting NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia
Conditions: Locally Advanced Pancreatic Cancer;   Metastatic Pancreatic Cancer
Intervention: Drug: Nanoplatin (NC-6004) and Gemcitabine
11 Completed Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: hMN14 (labetuzumab)
12 Recruiting Trial of Curcumin in Advanced Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Adenocarcinoma
Intervention: Drug: Curcumin
13 Completed Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
Conditions: Pancreatic Cancer;   Pancreatic Neoplasm
Interventions: Drug: Gemcitabine;   Drug: Herceptin;   Procedure: Radiation therapy
14 Active, not recruiting Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies
Condition: Pancreatic Neoplasms
Intervention: Drug: Aroplatin (Liposomal NDDP, L-NDDP)
15 Active, not recruiting Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
Conditions: Stage IVA Pancreatic Cancer;   Stage III Pancreatic Cancer;   Adenocarcinoma of the Pancreas
Interventions: Drug: fluorouracil;   Drug: gemcitabine
16 Recruiting APRiCOT-P: Study to Evaluate the Safety and Efficacy of Apricoxib With Gemcitabine and Erlotinib in the Treatment of Patients With Advanced Pancreatic Cancer (TP2001-203)
Conditions: Advanced Pancreatic Cancer;   Metastatic Pancreatic Cancer
Interventions: Drug: apricoxib + gemcitabine + erlotinib;   Drug: placebo + gemcitabine + erlotinib
17 Completed Acupuncture For Pancreatic Cancer Pain
Conditions: Pancreatic Neoplasms;   Pain
Intervention: Procedure: Acupuncture
18 Completed Randomized Trial of EUS Neurolysis in Pancreas Cancer
Condition: Pancreatic Neoplasms
Intervention: Procedure: Celiac Plexus Neurolysis
19 Recruiting A Study for Patients With Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: LY2603618;   Drug: Gemcitabine
20 Recruiting Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: PEP02

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services